Managing dyslipidaemia in young adults.

Area of Science:

• Cardiology
• Preventive Medicine
• Public Health

Background:

• Indians exhibit early-onset atherosclerotic cardiovascular disease (ASCVD) with risk factors developing at a younger age.
• Elevated cholesterol levels in early life significantly contribute to atherosclerosis development.
• Dyslipidemia often remains asymptomatic, necessitating early screening and intervention.

Purpose of the Study:

• To provide insights into identifying and managing dyslipidemia in young adults aged 18-40 years.
• To emphasize the importance of aggressive management strategies for young ASCVD patients.
• To highlight the role of early detection in reducing future cardiovascular events.

Main Methods:

• Review of current literature on dyslipidemia management in young adults.
• Analysis of risk factors associated with early-onset ASCVD in the Indian population.
• Discussion of pharmacological and lifestyle interventions for dyslipidemia.

Main Results:

• Young ASCVD patients (18-40 years) require lipid-lowering therapy to achieve LDL-C < 55 mg/dL.
• Early detection and aggressive management of dyslipidemia, even in asymptomatic individuals, can decrease future cardiovascular events.
• Lifestyle modifications are primary, but pharmacotherapy (statins, non-statins) is indicated for specific cases (e.g., LDL-C > 160 mg/dL, high coronary calcium score, FH gene carriers).

Conclusions:

• Aggressive management of dyslipidemia in young adults is essential to curb the rising incidence of ASCVD.
• Early screening and intervention strategies are vital for preventing long-term cardiovascular complications.
• A combination of lifestyle changes and targeted pharmacotherapy should be employed based on individual risk profiles.